However, so far only a single study, has evaluated the combined efficacy of M and E to suppress Nrf2 pathway, in non-small cell lung cancer, but none has been reported in glioma (Yu et al., 2017). This evidence concerns the gene NFE2L2 and central nervous system cancer.